- Home
- SID vs DYN Comparison
SID vs DYN Comparison
Compare SID & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SID
- DYN
- Stock Information
- Founded
- SID 1941
- DYN 1984
- Country
- SID Brazil
- DYN United States
- Employees
- SID N/A
- DYN N/A
- Industry
- SID Steel/Iron Ore
- DYN Medicinal Chemicals and Botanical Products
- Sector
- SID Industrials
- DYN Health Care
- Exchange
- SID Nasdaq
- DYN Nasdaq
- Market Cap
- SID 1.9B
- DYN 1.4B
- IPO Year
- SID 1997
- DYN 2020
- Fundamental
- Price
- SID $1.51
- DYN $8.64
- Analyst Decision
- SID Strong Sell
- DYN Strong Buy
- Analyst Count
- SID 1
- DYN 15
- Target Price
- SID $1.30
- DYN $43.60
- AVG Volume (30 Days)
- SID 3.3M
- DYN 3.7M
- Earning Date
- SID 07-31-2025
- DYN 08-11-2025
- Dividend Yield
- SID 5.39%
- DYN N/A
- EPS Growth
- SID N/A
- DYN N/A
- EPS
- SID N/A
- DYN N/A
- Revenue
- SID $7,828,045,151.00
- DYN N/A
- Revenue This Year
- SID $7.14
- DYN N/A
- Revenue Next Year
- SID $3.79
- DYN N/A
- P/E Ratio
- SID N/A
- DYN N/A
- Revenue Growth
- SID 2.40
- DYN N/A
- 52 Week Low
- SID $1.27
- DYN $6.36
- 52 Week High
- SID $2.50
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- SID 52.19
- DYN 33.82
- Support Level
- SID $1.47
- DYN $8.06
- Resistance Level
- SID $1.56
- DYN $9.30
- Average True Range (ATR)
- SID 0.05
- DYN 0.58
- MACD
- SID 0.01
- DYN -0.13
- Stochastic Oscillator
- SID 80.00
- DYN 21.64
About SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.